Literature DB >> 16012411

The role of N-methyl-D-aspartate (NMDA) receptors in pain and morphine tolerance.

C E Inturrisi1.   

Abstract

To determine the importance of the N-methyl-D-aspartate (NMDA) receptor in pain hypersensitivity following injury, the NMDAR1 subunit was selectively deleted in the lumbar spinal cord of adult mice by the localized injection of an adeno-associated virus expressing the Cre recombinase into floxed NR1 mice. This procedure resulted in more than an 80% reduction in the expression of both NR1 mRNA and protein and a corresponding loss of NMDA, but not AMPA currents, in the lamina II neurons in the injected area. This spatially and temporally restricted knockout dramatically reduced the response to pain hypersensitivity resulting from the intraplantar injection of formalin but did not alter heat or cold paw withdrawal latencies, mechanical threshold, or motor function. Thus, the NMDA receptor in the spinal cord dorsal horn is essential for central sensitization, the central facilitation of pain transmission produced by peripheral injury. Agents that act on these spinal receptors may provide a therapeutic approach to ameliorate injury-induced pain.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16012411

Source DB:  PubMed          Journal:  Minerva Anestesiol        ISSN: 0375-9393            Impact factor:   3.051


  12 in total

1.  The expression of NMDA receptor subunits in cerebral cortex and hippocampus is differentially increased by administration of endobain E, a Na+, K+-ATPase inhibitor.

Authors:  María Geraldina Bersier; Clara Peña; Georgina Rodríguez de Lores Arnaiz
Journal:  Neurochem Res       Date:  2007-08-08       Impact factor: 3.996

Review 2.  NMDA neurotransmission as a critical mediator of borderline personality disorder.

Authors:  Bernadette Grosjean; Guochuan E Tsai
Journal:  J Psychiatry Neurosci       Date:  2007-03       Impact factor: 6.186

3.  Evaluation of the reinforcing and subjective effects of heroin in combination with dextromethorphan and quinidine.

Authors:  Suzanne K Vosburg; Maria A Sullivan; Sandra D Comer
Journal:  J Opioid Manag       Date:  2011 Nov-Dec

4.  Inflammatory pain-induced signaling events following a conditional deletion of the N-methyl-D-aspartate receptor in spinal cord dorsal horn.

Authors:  H T Cheng; M Suzuki; D M Hegarty; Q Xu; A R Weyerbacher; S M South; M Ohata; C E Inturrisi
Journal:  Neuroscience       Date:  2008-06-19       Impact factor: 3.590

Review 5.  Methadone: a new old drug with promises and pitfalls.

Authors:  Jodie A Trafton; Abhinav Ramani
Journal:  Curr Pain Headache Rep       Date:  2009-02

6.  Potential for Precision Medicine in Methadone Treatment of Opioid Use Disorder.

Authors:  Andrew J Saxon
Journal:  J Addict Med       Date:  2020 Sep/Oct       Impact factor: 4.647

Review 7.  Effect of magnesium added to local anesthetics for caudal anesthesia on postoperative pain in pediatric surgical patients: A systematic review and meta-analysis with Trial Sequential Analysis.

Authors:  Hiromasa Kawakami; Takahiro Mihara; Nobuhito Nakamura; Koui Ka; Takahisa Goto
Journal:  PLoS One       Date:  2018-01-02       Impact factor: 3.240

8.  The multiple PDZ domain protein Mpdz/MUPP1 regulates opioid tolerance and opioid-induced hyperalgesia.

Authors:  Robin Donaldson; Yuan Sun; De-Yong Liang; Ming Zheng; Peyman Sahbaie; David L Dill; Gary Peltz; Kari J Buck; J David Clark
Journal:  BMC Genomics       Date:  2016-04-29       Impact factor: 3.969

9.  Tyrosine Kinase Inhibitors Reduce NMDA NR1 Subunit Expression, Nuclear Translocation, and Behavioral Pain Measures in Experimental Arthritis.

Authors:  Karin N Westlund; Ying Lu; Liping Zhang; Todd C Pappas; Wen-Ru Zhang; Giulio Taglialatela; Sabrina L McIlwrath; Terry A McNearney
Journal:  Front Physiol       Date:  2020-05-27       Impact factor: 4.566

10.  Involvement of EphB1 receptors signalling in models of inflammatory and neuropathic pain.

Authors:  Vincent Cibert-Goton; Guanglu Yuan; Anna Battaglia; Sarah Fredriksson; Mark Henkemeyer; Thomas Sears; Isabella Gavazzi
Journal:  PLoS One       Date:  2013-01-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.